Article
Procalcitonin (PCT) Predicts Worse Outcome in Patients with Chronic Heart Failure with…
Disease Markers · 2018 · J. Banach, author Ł. Wołowiec, author D. Rogowicz, author L. Gackowska, author I. Kubiszewska, author W. Gilewski, author J. Michałkiewicz, author W. Sinkiewicz, author Marco Proietti, Academic Editor
Key facts
| Title | Procalcitonin (PCT) Predicts Worse Outcome in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF) |
|---|---|
| First author | J. Banach, author Ł. Wołowiec, author D. Rogowicz, author L. Gackowska, author I. Kubiszewska, author W. Gilewski, author J. Michałkiewicz, author W. Sinkiewicz, author Marco Proietti, Academic Editor |
| Journal | Disease Markers |
| Published | Mar 18, 2018 |
| DOI | 10.1155/2018/9542784 |
| Devices mentioned | BK230839, BK230840, K000042, K000155, K000270, K000576, K001014, K001015, K001468, K001846, K001906, K002148 and 186 more |
| Product codes mentioned | CDD, CDP, CDX, CDZ, CEC, CEP, CEW, CFL, CFP, CFT, CGJ, CGN and 62 more |
At a glance
- 100–999 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1